Das Produkt wurde korrekt in den Warenkorb gelegt.

discount label
Salivary peptide gSG6-P1
3D-Ansicht

Biosynth logo

Salivary peptide gSG6-P1

Ref. 3D-PP42840

1mg
422,00 €
10mg
455,00 €
100mg
925,00 €
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 14. Januar 2025

Produktinformation

Name:
Salivary peptide gSG6-P1
Synonyme:
  • H-EKVWVDRDNVYCGHLDCTRVATF-OH H-Glu-Lys-Val-Trp-Val-Asp-Arg-Asp-Asn-Val-Tyr-Cys-Gly-His-Leu-Asp-Cys-Thr-Arg-Val-Ala-Thr-Phe-OH
Beschreibung:

Peptide Salivary peptide gSG6-P1 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Salivary peptide gSG6-P1 include the following: Roles of the P1, P2, and P3 residues in determining inhibitory specificity of kallistatin toward human tissue kallikrein VC Chen, L Chao, J Chao - Journal of Biological Chemistry, 2000 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)55977-4/abstract Deconvoluting the Structural and Drug-Recognition Complexity of the G-Quadruplex-Forming Region Upstream of the bcl-2 P1 Promoter TS Dexheimer , D Sun, LH Hurley - Journal of the American , 2006 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ja0563861 Asymptotic Telegrapher's Equation (P1) Approximation for the Transport Equation SI Heizler - Nuclear science and engineering, 2010 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.13182/NSE09-77 The i-Motif in the bcl-2 P1 Promoter Forms an Unexpectedly Stable Structure with a Unique 8:5:7 Loop Folding Pattern S Kendrick , Y Akiyama, SM Hecht - Journal of the American , 2009 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ja9076292 P1 or P1¯? Or something else? RE Marsh - Acta Crystallographica Section B: Structural Science, 1999 - scripts.iucr.orghttps://scripts.iucr.org/cgi-bin/paper?bk0068 The P1' specificity of tobacco etch virus protease RB Kapust, J Tözser , TD Copeland - and biophysical research , 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X02005740 A new bacteriophage P1-derived vector for the propagation of large human DNA fragments PA Loannou, CT Amemiya , J Garnes, PM Kroisel - Nature , 1994 - nature.comhttps://www.nature.com/articles/ng0194-84 Bacteriophage P1 site-specific recombination: I. Recombination between loxP sites N Sternberg, D Hamilton - Journal of molecular biology, 1981 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0022283681903752 Bacteriophage P1 cloning system for the isolation, amplification, and recovery of DNA fragments as large as 100 kilobase pairs. N Sternberg - Proceedings of the National Academy of , 1990 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.87.1.103 Solution equilibria of the i-motif-forming region upstream of the B-cell lymphoma-2 P1 promoter N Khan , A Avia+M951 , R Tauler , C Gonzalez , R Eritja - Biochimie, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0300908407002027 Non-spatial attentional effects on P1 MJ Taylor - Clinical neurophysiology, 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1388245702003097 Genome of bacteriophage P1 MB à obocka , DJ Rose, G Plunkett III - Journal of , 2004 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jb.186.21.7032-7068.2004 Substrate specificity of schistosome versus human legumain determined by P1-P3 peptide libraries MA Mathieu, M Bogyo , CR Caffrey, Y Choe - Molecular and , 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0166685102000269 Arg-Gly-Asp constrained within cyclic pentapoptides Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1 M Aumailley, M Gurrath, G Muller, J Calvete , R Timpl - FEBS letters, 1991 - Elsevierhttps://www.sciencedirect.com/science/article/pii/001457939181101D E. coli Genome Manipulation by P1 Transduction LC Thomason, N Costantino - Current protocols in , 2007 - Wiley Online Libraryhttps://currentprotocols.onlinelibrary.wiley.com/doi/abs/10.1002/0471142727.mb0117s79 Symmetry determination following structure solution in P1 L Palatinus , A van der Lee - Journal of Applied Crystallography, 2008 - scripts.iucr.orghttps://scripts.iucr.org/cgi-bin/paper?db5046 New Brazilian variant of the SARS-CoV-2 (P1/Gamma) of COVID-19 in Alagoas state JC da Silva , VB Felix , SABF Leo - Brazilian Journal of , 2021 - SciELO Brasilhttps://www.scielo.br/j/bjid/a/c4vhXLBKnZQKkQd83H3JxMS/ Efficacy, safety, and immunogenicity of a meningococcal group B (15: P1. 3) outer membrane protein vaccine in Iquique, Chile J Boslego, J Garcia, C Cruz, W Zollinger, B Brandt - Vaccine, 1995 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0264410X9400037N Cementum protein 1-derived peptide (CEMP 1-p1) modulates hydroxyapatite crystal formation in vitro G Montoya, R Correa , J Arenas , L Hoz - Journal of Peptide , 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.3211 Impact of ectoenzymes on p2 and p1 receptor signaling F Kukulski, SA Levesque , J Sevigny - Advances in pharmacology, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/B9780123855268000096 Transduction of linked genetic characters of the host by bacteriophage P1. ES Lennox - 1955 - cabidigitallibrary.orghttps://www.cabidigitallibrary.org/doi/full/10.5555/19562701727 Case study of two post vaccination SARS-CoV-2 infections with P1 variants in CoronaVac vaccinees in Brazil CF Estofolete, CA Banho , GRF Campos , BC Marques - Viruses, 2021 - mdpi.comhttps://www.mdpi.com/1999-4915/13/7/1237 First attempt to validate the gSG6-P1 salivary peptide as an immuno-epidemiological tool for evaluating human exposure to Anopheles funestus bites A Poinsignon , B Samb, S Doucoure - Tropical Medicine & , 2010 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-3156.2010.02611.x

Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:

Chemische Eigenschaften

Molekulargewicht:
2,727.07 g/mol
Formel:
C119H180N34O36S2
MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:

Gefahrenhinweise

UN-Nummer:
EQ:
Klasse:
H-Sätze:
P-Sätze:
Flugverbot:
Gefahrenhinweis:
Verpackungsgruppe:
LQ:

Technische Anfrage zu: 3D-PP42840 Salivary peptide gSG6-P1

Bitte verwenden Sie stattdessen den Warenkorb, um ein Angebot oder eine Bestellung anzufordern

Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.

* Obligatorische felder
Willkommen bei CymitQuimica!Wir verwenden Cookies, um Ihren Besuch zu verbessern. Wir schließen Werbung nicht ein.

Bitte beachten Sie unsere Cookie-Richtlinie  für weitere Details oder passen Sie Ihre Einstellungen unter “Konfigurieren” an.